Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Smouldering disease in paediatric-onset multiple sclerosis
Massimo Filippi, Monica Margoni, Brenda Banwell, Tanuja Chitnis, Russell C. Dale, Giulia Fadda, Yael Hacohen, Lauren Krupp, Paolo Preziosa, E. Ann Yeh, Emmanuelle Waubant, Maria A. Rocca (2025). Smouldering disease in paediatric-onset multiple sclerosis. , 120, DOI: https://doi.org/10.1016/j.ebiom.2025.105921.
Article14 days agoCervical spinal cord gray matter damage predicts disability worsening in multiple sclerosis: a longitudinal study
Matteo Azzimonti, Paolo Preziosa, Elisabetta Pagani, Alessandro Meani, Monica Margoni, Martina Rubin, Mor Gueye, Federica Esposito, Massimo Filippi, Maria A. Rocca (2025). Cervical spinal cord gray matter damage predicts disability worsening in multiple sclerosis: a longitudinal study. , 272(3), DOI: https://doi.org/10.1007/s00415-025-12979-4.
Article14 days agoSpinal Cord Abnormalities in Early Pediatric Multiple Sclerosis
Monica Margoni, Paola Valsasina, Paolo Preziosa, Martina Rubin, Mor Gueye, Lucia Moiola, Maria A. Rocca, Massimo Filippi (2025). Spinal Cord Abnormalities in Early Pediatric Multiple Sclerosis. , 12(9), DOI: https://doi.org/10.1002/acn3.70046.
Article14 days agoSoma and neurite density abnormalities of paramagnetic rim lesions and core-sign lesions in multiple sclerosis
Paolo Preziosa, Elisabetta Pagani, Alessandro Meani, Monica Margoni, Martina Rubin, Federica Esposito, Marco Palombo, Massimo Filippi, Maria A. Rocca (2025). Soma and neurite density abnormalities of paramagnetic rim lesions and core-sign lesions in multiple sclerosis. , 272(2), DOI: https://doi.org/10.1007/s00415-025-12887-7.
Article14 days agoPharmacodynamics and Pharmacokinetics of Ublituximab Compared with Other Anti-Cd20 Monoclonal Antibodies for Multiple Sclerosis Treatment
Monica Margoni, Luca Battistini, Diego Centonze, Roberto Furlan, Claudio Gasperini, Massimo Filippi (2025). Pharmacodynamics and Pharmacokinetics of Ublituximab Compared with Other Anti-Cd20 Monoclonal Antibodies for Multiple Sclerosis Treatment. , 23, DOI: https://doi.org/10.2174/011570159x392955250815095236.
Article14 days ago